Discover 1,307 paid clinical trials in Columbus, Ohio. Search by condition or phase to find a research study near you that matches your needs across various therapeutic areas.
Columbus hosts a variety of active clinical studies, including for conditions such as diabetes, asthma, and cardiovascular diseases. The city's prominent healthcare institutions are recruiting participants, both as healthy volunteers seeking paid research opportunities and individuals in need of trials for specific conditions, offering access to new and innovative treatments and therapies.
Filter
2
Filter results
Results: 1,307
Safety and Tolerability of TNG456 Alone and in Combination With Abemaciclib in Patients With Solid Tumors With MTAP Loss
for
Non Small Cell Lung Cancer, Glioma Glioblastoma Multiforme,
Location: Columbus OH, Chicago IL, Fairfax VA, Washington D.C. DC,
Sponsor: Tango Therapeutics, Inc.
Sex: All
Age: 18+
Code: NCT06810544
Phase 1, Phase 2, Recruiting
The Ohio State University (OSU) SCREEN Community Program
for
Breast Carcinoma, Cervical Carcinoma, Colorectal Carcinoma
Location: Columbus OH
Sponsor: Ohio State University Comprehensive Cancer Center
Sex: All
Age: 0+
Code: NCT06666192
Recruiting
Testing Lutetium Lu 177 Dotatate in Patients With Somatostatin Receptor Positive Advanced Bronchial Neuroendocrine Tumors
for
Advanced Lung Neuroendocrine Tumor,
Location: Columbus OH, Cleveland OH, Pittsburgh PA, Chicago IL,
Sponsor: National Cancer Institute (NCI)
Sex: All
Age: 18+
Code: NCT04665739
Phase 2, Recruiting
A Study of Azenosertib (ZN-c3) in Subjects With Platinum-Resistant High-Grade Serous Ovarian, Fallopian Tube or Primary Peritoneal Cancer
for
High-Grade Serous Ovarian, Fallopian Tube or Primary Peritoneal Cancer,
Sponsor: K-Group, Beta, Inc., a wholly owned subsidiary of Zentalis Pharmaceuticals, Inc
Sex: Female
Age: 18+
Code: NCT05128825
Phase 2, Recruiting
Canakinumab for the Prevention of Progression to Cancer in Patients With Clonal Cytopenias of Unknown Significance, IMPACT Study
for
Clonal Cytopenia of Undetermined Significance
Location: Columbus OH, Nashville TN, New York NY, Dallas TX,
Sponsor: Uma Borate
Sex: All
Age: 18+
Code: NCT05641831
Phase 2, Recruiting
Interested in new trials?
Get alerts for new trials in your area by subscribing now
Evaluation of Endoscopic Ultrasound-Guided Radiofrequency Ablation for the Management of Pancreatic Tumors, ERASE Study
for
Pancreatic Neoplasm
Location: Columbus OH
Sponsor: Ohio State University Comprehensive Cancer Center
Sex: All
Age: 18+
Code: NCT05961982
Recruiting
Comparing Retreatment of 177Lu-DOTATATE PRRT Versus the Usual Treatment in Patients With Metastatic Unresectable Gastroenteropancreatic Neuroendocrine Tumors, NET RETREAT Trial
for
Metastatic Digestive System Neuroendocrine Tumor G1,
Location: Columbus OH, London, Crown Point IN, Chicago IL,
Sponsor: National Cancer Institute (NCI)
Sex: All
Age: 18+
Code: NCT05773274
Phase 2, Recruiting
Phase 2 Study of Glofitamab Monotherapy & With Polatuzumab Vedotin, Pirtobrutinib, or Atezolizumab in Richter's Transformation
Location: Columbus OH, Chapel Hill NC, Atlanta GA, Boston MA
Sponsor: Christine Ryan
Sex: All
Age: 18+
Code: NCT06043674
Phase 2, Recruiting
Intralesional Influenza Vaccine for the Treatment of Stage I-IV Melanoma
for
Clinical Stage I Cutaneous Melanoma AJCC v8,
Location: Columbus OH
Sponsor: Carlo Contreras
Sex: All
Age: 18 - 70+
Code: NCT04697576
Phase 1, Recruiting
Testing the Addition of Anti-Cancer Drug, ZEN003694 (ZEN-3694) and PD-1 Inhibitor (Pembrolizumab), to Standard Chemotherapy (Nab-Paclitaxel) Treatment in Patients With Advanced Triple-Negative Breast Cancer
for
Anatomic Stage III Breast Cancer AJCC v8,
Location: Columbus OH, Nashville TN, New York NY, Mineola NY,
Sponsor: National Cancer Institute (NCI)
Sex: All
Age: 18+
Code: NCT05422794
Phase 1, Recruiting
Safety and Efficacy of KRT-232 in Combination With Acalabrutinib in Subjects With R/R DLBCL or R/R CLL
for
Diffuse Large B Cell Lymphoma, Chronic Lymphocytic Leukemia,
Location: Columbus OH, Cincinnati OH, Goshen IN, Dallas TX
Sponsor: Kartos Therapeutics, Inc.
Sex: All
Age: 18+
Code: NCT04502394
Phase 1, Phase 2, Recruiting
Evaluation of Geriatric Assessment and Management for Older Adults With Non-small Cell Lung Cancer Receiving Chemotherapy Radiation Therapy
for
Lung Non-Small Cell Carcinoma, Stage III Lung Cancer AJCC v8
Location: Columbus OH, Duarte CA
Sponsor: City of Hope Medical Center
Sex: All
Age: 60+
Code: NCT06139627
Recruiting
Temozolomide and Atezolizumab for Subsequent Line for the Treatment of Metastatic or Recurrent Small Cell Lung Cancer
for
Extensive Stage Lung Small Cell Carcinoma,
Location: Columbus OH, Indianapolis IN, Chicago IL, Madison WI,
Sponsor: Dwight Owen
Sex: All
Age: 18+
Code: NCT04919382
Phase 2, Recruiting
SNDX-5613 and Gilteritinib for the Treatment of Relapsed or Refractory FLT3-Mutated Acute Myeloid Leukemia and Concurrent MLL-Rearrangement or NPM1 Mutation
for
Acute Myeloid Leukemia With FLT3/ITD Mutation,
Location: Columbus OH, Chapel Hill NC, Madison WI,
Sponsor: Uma Borate
Sex: All
Age: 18+
Code: NCT06222580
Phase 1, Recruiting
Delayed or Upfront Brain RAdiotherapy in Treatment naïve Lung Cancer Patients With Asymptomatic or Minimally Symptomatic Brain Metastases and ALK rEarrangements
for
Lung Cancer, NSCLC, Brain Metastases
Location: Columbus OH, Aurora CO, Stanford CA
Sponsor: Joshua Palmer
Sex: All
Age: 18+
Code: NCT05987644
Phase 1, Phase 2, Recruiting
Chemotherapy With or Without Immunotherapy for Peritoneal Mesothelioma
for
Peritoneal Malignant Mesothelioma
Location: Columbus OH, Pittsburgh PA, Danville IL, Chicago IL,
Sponsor: National Cancer Institute (NCI)
Sex: All
Age: 18+
Code: NCT05001880
Phase 2, Recruiting
Living Well With Advanced Breast Cancer
for
Advanced Breast Carcinoma,
Location: Columbus OH
Sponsor: Ohio State University Comprehensive Cancer Center
Sex: All
Age: 18+
Code: NCT07227038
Recruiting
Prospective Multiomic Analysis in Small-Cell Lung Cancer
for
Small Cell Cancer Of The Lung, Small Cell Lung Cancer ( SCLC ),
Location: Columbus OH
Sponsor: Ohio State University Comprehensive Cancer Center
Sex: All
Age: 18+
Code: NCT07795411
Recruiting
Evaluating the Addition of the Immunotherapy Drug Atezolizumab to Standard Chemotherapy Treatment for Advanced or Metastatic Neuroendocrine Carcinomas That Originate Outside the Lung